New Edition of Cancer Care’s Helping Hand Available

Publication
Article
OncologyONCOLOGY Vol 16 No 8
Volume 16
Issue 8

Cancer Care has published the fourth edition of its handbook-A Helping Hand: The Resource Guide for People With Cancer. The 148-page booklet contains listings and descriptions of organizations that offer a wide variety of services, support, and information for people with cancer. In general, the booklet shows cancer patients what types of help are available to them and where they can find it, both nationally and regionally. Listings include cancer centers, commercial services that offer products of particular interest to people with cancer (such as wigs and prostheses), state pharmaceutical assistance programs, pharmaceutical manufacturers’ indigent drug programs, and useful tips on what to ask when contacting such services.

Cancer Care has published the fourth edition of itshandbook—A Helping Hand: The Resource Guide for People With Cancer. The148-page booklet contains listings and descriptions of organizations that offera wide variety of services, support, and information for people with cancer. Ingeneral, the booklet shows cancer patients what types of help are available tothem and where they can find it, both nationally and regionally. Listingsinclude cancer centers, commercial services that offer products of particularinterest to people with cancer (such as wigs and prostheses), statepharmaceutical assistance programs, pharmaceutical manufacturers’ indigentdrug programs, and useful tips on what to ask when contacting such services.

The booklet can be ordered by calling 1-800-813-4673 and is available as asearchable database on Cancer Care’s website, www.cancercare.org.

Recent Videos
Lisa J. States, MD, discussed further steps for improving early detection and screening methods in patients with Li–Fraumeni syndrome.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
9 Experts are featured in this series.
9 Experts are featured in this series.
Additional genetic testing measures and targeted therapies may improve outcomes for patients with diverse molecular subgroups of gastric cancers.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
Related Content